Atlas Trials

Allogeneic Umbilical Cord Mesenchymal Stromal Cells for the Treatment of Chronic Antibody-Mediated Rejection in Kidney Transplantation

Clinical trial NCT06886646 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06886646
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Antibody-mediated Rejection (cABMR)
Start date
2025-09-15
Primary completion
2027-09-15
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.